vaccine-development

Special Antigen Peptides in Vaccines and Immunotherapy

Special antigen peptides, short amino acid chains of 5 to 50 residues, mimic protein epitopes from diseases like infections, cancers, and autoimmune conditions. They drive immune responses in vaccine development, immunotherapy, and diagnostics without causing illness. Design involves bioinformatics for epitope selection, optimization for stability, and synthesis methods like solid-phase techniques.